ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 198 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $210,000 | -20.2% | 16,920 | -11.7% | 0.00% | – |
Q3 2016 | $263,000 | +97.7% | 19,154 | +6.1% | 0.00% | – |
Q2 2016 | $133,000 | +79.7% | 18,045 | +56.0% | 0.00% | – |
Q1 2016 | $74,000 | +124.2% | 11,571 | +119.3% | 0.00% | – |
Q4 2015 | $33,000 | +32.0% | 5,276 | +19.7% | 0.00% | – |
Q3 2015 | $25,000 | -32.4% | 4,408 | 0.0% | 0.00% | – |
Q2 2015 | $37,000 | -7.5% | 4,408 | -8.4% | 0.00% | – |
Q1 2015 | $40,000 | +21.2% | 4,811 | 0.0% | 0.00% | – |
Q4 2014 | $33,000 | +26.9% | 4,811 | 0.0% | 0.00% | – |
Q3 2014 | $26,000 | -16.1% | 4,811 | 0.0% | 0.00% | – |
Q2 2014 | $31,000 | -61.7% | 4,811 | -52.5% | 0.00% | – |
Q1 2014 | $81,000 | +5.2% | 10,133 | -10.5% | 0.00% | – |
Q4 2013 | $77,000 | -88.4% | 11,317 | -68.7% | 0.00% | -100.0% |
Q3 2013 | $666,000 | +142.2% | 36,183 | +130.1% | 0.00% | 0.0% |
Q2 2013 | $275,000 | – | 15,724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |